Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases.
Kamyar GhabiliAustin-Marley Windham-HermanMenelaos KonstantinidisNikitha MuraliTabea BordeLucas C AdamFabian Laage-GauppMingDe LinJulius ChapiroChristos GeorgiadesNariman NezamiPublished in: Annals of hepatology (2024)
Repeat cTACE in the management of liver metastases from NET, CRC, and lung cancer was associated with improved patient survival. We recommend at least four cTACE sessions before switching to another treatment for nonresponding metastatic liver lesions.